Onconetix, Inc. Defined Benefit Plan, Accumulated Benefit Obligation
Onconetix, Inc. (ONCO) had Defined Benefit Plan, Accumulated Benefit Obligation of $427.09 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Additional Information
us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation · last filed 2026-03-13
- 2025-06-30: Defined Benefit Plan, Accumulated Benefit Obligation $427.09K.
- 2025-03-31: Defined Benefit Plan, Accumulated Benefit Obligation $2.45M.
- 2024-12-31: Defined Benefit Plan, Accumulated Benefit Obligation $2.59M; Defined Benefit Plan, Accumulated Benefit Obligation as first filed $2.67M.
- 2023-12-31: Defined Benefit Plan, Accumulated Benefit Obligation $2.30M.
| Period end | Defined Benefit Plan, Accumulated Benefit Obligation | Defined Benefit Plan, Accumulated Benefit Obligation as first filed |
|---|---|---|
| 2025-06-30 | $427.09K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.45M 10-Q · filed 2025-06-12 | |
| 2024-12-31 | $2.59M 10-K · filed 2026-03-13 | $2.67M 10-K · filed 2025-06-02 |
| 2023-12-31 | $2.30M 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |